A Phase 1 Open Label, Two-arm, Fixed Sequence, Crossover Study to Investigate the Effects of Itraconazole and Carbamazepine on the Pharmacokinetics of BAY 2927088 in Healthy Participants
Latest Information Update: 24 Jun 2024
At a glance
- Drugs BAY 2927088 (Primary) ; Carbamazepine; Itraconazole
- Indications Non-small cell lung cancer
- Focus Pharmacokinetics
- Sponsors Bayer
- 18 Jun 2024 Status changed from recruiting to completed.
- 29 Apr 2024 Status changed from not yet recruiting to recruiting.
- 09 Apr 2024 New trial record